Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2020

May 4, 2020

35380_dirs_2020-05-04_588bf33e-df23-458b-890a-f33df60d0ae3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2020-05-01

Reporting Person: Murphy Kimberly M (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-01 Non-Employee Director Option (Right to Buy) $0.4327 A 138664 Acquired 2030-05-01 Common Stock (138664) Direct

Footnotes

F1: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vests immediately.